新技术制剂 - 新济药业

Chip center 2013年起源于广电产品，致力发展智能终端平台

Core Products

产品名称：
Osmotic Pump

上市Date： 2020-01-06

核心功能

功效：

Number	Entry Name	Classification	Indications	Specs
1	Glipizide Sustained-Release Tablets	Types III	Type II Diabetes	2.5mg 10mg
2	Oxybunin Controlled Release Tablets	Types III	Overactive Bladder	5mg 10mg
3	Oxybunin Controlled Release Tablets	Types IV	Attention Deficit Disorder	18mg 54mg
4	Paliperidone Controlled Release Tablets	Types III	Schizophrenia	3mg 9mg

Number	Entry Name	Classification	Indications	Specs
1	Glipizide Sustained-Release Tablets	Types III	Type II Diabetes	2.5mg 10mg
2	Oxybunin Controlled Release Tablets	Types III	Overactive Bladder	5mg 10mg
3	Oxybunin Controlled Release Tablets	Types IV	Attention Deficit Disorder	18mg 54mg
4	Paliperidone Controlled Release Tablets	Types III	Schizophrenia	3mg 9mg

返回列表

Prev：Compression-Coated TabletsNext：Pellets

Advisory Service Hotline

020-31135057

Rhino Cloud provides enterprise cloud services

WeChat Public